Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.12 USD
Change Today -0.05 / -0.81%
Volume 35.2K
CPIX On Other Exchanges
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James L. Herman

Chief Compliance Officer and Vice President of National Accounts, Cumberland Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Mr. James Lowrance Herman serves as Vice President of National Accounts and Chief Compliance Officer at Cumberland Pharmaceuticals, Inc. Mr. Herman served as Senior Director of National Accounts and Corporate Compliance Officer of Cumberland Pharmaceuticals, Inc. He is responsible for all national accounts sales, including wholesalers and retail chain buying offices, managed care home Cumberland Pharmaceuticals, Inc. offices and federal government accounts. He is also ...

Read Full Background

Corporate Headquarters*

2525 West End Avenue
Nashville, Tennessee 37203

United States

Phone: 615-255-0068
Fax: 615-255-0094

Board Members Memberships*

There is no Board Members Memberships data available.


Indiana University, Bloomington
Cardinal Stritch University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$239,250

Stock Options*

Restricted Stock Awards$35,495

Total Compensation*

Total Annual Cash Compensation$239,250
Total Short Term Compensation$239,250
Other Long Term Compensation$35,495
Total Calculated Compensation$299,745
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CPIX:US $6.12 USD -0.05


David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
Rajat Rai Chief Executive Officer
Akorn, Inc.
Peter S. Greenleaf Chief Executive Officer and Director
Sucampo Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CUMBERLAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at